Whitehawk Therapeutics, Stock Forecast - Double Exponential Smoothing

WHWK Stock   2.72  0.07  2.64%   
The Double Exponential Smoothing forecasted value of Whitehawk Therapeutics, on the next trading day is expected to be 2.67 with a mean absolute deviation of 0.1 and the sum of the absolute errors of 5.82. Whitehawk Stock Forecast is based on your current time horizon. Although Whitehawk Therapeutics,'s naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Whitehawk Therapeutics,'s systematic risk associated with finding meaningful patterns of Whitehawk Therapeutics, fundamentals over time.
At this time, Whitehawk Therapeutics,'s Inventory Turnover is quite stable compared to the past year. Payables Turnover is expected to rise to 26.29 this year, although the value of Receivables Turnover will most likely fall to 3.30. . The value of Common Stock Shares Outstanding is expected to slide to about 20.4 M.

Open Interest Against 2026-02-20 Whitehawk Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Whitehawk Therapeutics,'s spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Whitehawk Therapeutics,'s options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Whitehawk Therapeutics, stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Whitehawk Therapeutics,'s open interest, investors have to compare it to Whitehawk Therapeutics,'s spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Whitehawk Therapeutics, is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Whitehawk. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Whitehawk Therapeutics, works best with periods where there are trends or seasonality.

Whitehawk Therapeutics, Double Exponential Smoothing Price Forecast For the 25th of December

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Whitehawk Therapeutics, on the next trading day is expected to be 2.67 with a mean absolute deviation of 0.1, mean absolute percentage error of 0.02, and the sum of the absolute errors of 5.82.
Please note that although there have been many attempts to predict Whitehawk Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Whitehawk Therapeutics,'s next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Whitehawk Therapeutics, Stock Forecast Pattern

Backtest Whitehawk Therapeutics,Whitehawk Therapeutics, Price PredictionBuy or Sell Advice 

Whitehawk Therapeutics, Forecasted Value

In the context of forecasting Whitehawk Therapeutics,'s Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Whitehawk Therapeutics,'s downside and upside margins for the forecasting period are 0.03 and 9.16, respectively. We have considered Whitehawk Therapeutics,'s daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
2.72
2.67
Expected Value
9.16
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Whitehawk Therapeutics, stock data series using in forecasting. Note that when a statistical model is used to represent Whitehawk Therapeutics, stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0051
MADMean absolute deviation0.0987
MAPEMean absolute percentage error0.0426
SAESum of the absolute errors5.8247
When Whitehawk Therapeutics, prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Whitehawk Therapeutics, trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Whitehawk Therapeutics, observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Whitehawk Therapeutics,

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Whitehawk Therapeutics,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Whitehawk Therapeutics,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.142.769.25
Details
Intrinsic
Valuation
LowRealHigh
0.112.208.69
Details

Other Forecasting Options for Whitehawk Therapeutics,

For every potential investor in Whitehawk, whether a beginner or expert, Whitehawk Therapeutics,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Whitehawk Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Whitehawk. Basic forecasting techniques help filter out the noise by identifying Whitehawk Therapeutics,'s price trends.

Whitehawk Therapeutics, Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Whitehawk Therapeutics, stock to make a market-neutral strategy. Peer analysis of Whitehawk Therapeutics, could also be used in its relative valuation, which is a method of valuing Whitehawk Therapeutics, by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Whitehawk Therapeutics, Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Whitehawk Therapeutics,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Whitehawk Therapeutics,'s current price.

Whitehawk Therapeutics, Market Strength Events

Market strength indicators help investors to evaluate how Whitehawk Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Whitehawk Therapeutics, shares will generate the highest return on investment. By undertsting and applying Whitehawk Therapeutics, stock market strength indicators, traders can identify Whitehawk Therapeutics, entry and exit signals to maximize returns.

Whitehawk Therapeutics, Risk Indicators

The analysis of Whitehawk Therapeutics,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Whitehawk Therapeutics,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting whitehawk stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Whitehawk Therapeutics, is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Whitehawk Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Whitehawk Therapeutics, Stock. Highlighted below are key reports to facilitate an investment decision about Whitehawk Therapeutics, Stock:
Check out Historical Fundamental Analysis of Whitehawk Therapeutics, to cross-verify your projections.
For more information on how to buy Whitehawk Stock please use our How to buy in Whitehawk Stock guide.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Whitehawk Therapeutics,. If investors know Whitehawk will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Whitehawk Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.15
Revenue Per Share
0.92
Quarterly Revenue Growth
0.335
Return On Assets
(0.22)
Return On Equity
0.1769
The market value of Whitehawk Therapeutics, is measured differently than its book value, which is the value of Whitehawk that is recorded on the company's balance sheet. Investors also form their own opinion of Whitehawk Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Whitehawk Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Whitehawk Therapeutics,'s market value can be influenced by many factors that don't directly affect Whitehawk Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Whitehawk Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Whitehawk Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Whitehawk Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.